Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boundless Regenerative Medicine is a biotechnology company that develops and distributes advanced regenerative biologics derived from human birth tissues. The company's product line includes amniotic fluid-derived injectables and membrane allografts, such as Boundless and Boundless Flow, which are designed to support tissue repair and modulate inflammation. These products are utilized by clinicians in fields such as orthopedics, sports medicine, and wound care to treat conditions like osteoarthritis and chronic wounds. By leveraging the natural concentrations of growth factors, cytokines, and hyaluronic acid found in placental tissues, Boundless Regenerative Medicine provides minimally invasive alternatives to traditional surgical interventions. The company is headquartered in Lakewood, Colorado, and focuses on providing high-quality, shelf-stable biological solutions for clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boundless Regenerative Medicine.